RIPPLE THERAPEUTICS CORP has a total of 18 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are MOUSA SHAKER A, CUI KUNFENG and UNIV GUANGXI CHINESE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Textiles and paper | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Steroids | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Heterocyclic compounds | |
#6 | Syringes | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Shaping of plastics | |
#9 | Manufacturing artificial filaments | |
#10 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Statham Matthew Alexander John | 14 |
#2 | Louka Dimitra | 14 |
#3 | Parrag Ian Charles | 14 |
#4 | Fischer Hans Christian | 12 |
#5 | Naimark Wendy Alison | 12 |
#6 | Santerre J Paul | 11 |
#7 | Battiston Kyle | 10 |
#8 | Parrag Ian | 4 |
#9 | Battiston Kyle Giovanni | 3 |
#10 | Naimark Wendy | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021024041A1 | Controlled release drug dimers | |
WO2021014217A1 | Articles comprising steroid dimers and their use in the delivery of therapeutic agents | |
WO2021005417A1 | Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereof | |
US2021113780A1 | Intravitreal injector | |
WO2020154815A1 | Crystalline forms of dexamethasone dimers and uses thereof |